⌘K

Home/Filings/4/0001493152-19-012854

4//SEC Filing

GLECKEL LOUIS MD 4

Accession 0001493152-19-012854

CIK 0000868278other

View on SEC.gov Company Profile

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 4:00 PM ET

Size

4.8 KB

Accession

0001493152-19-012854

Insider Transaction Report

Form 4

Period: 2019-07-01

ProPhase Labs, Inc.PRPH

GLECKEL LOUIS MD

10% Owner

Transactions

Award
Common Stock, par value $0.0005
2019-07-01$2.38/sh+4,727$11,250→ 98,590 total

Footnotes (1)

[F1]These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1

filerCIK 0001164762

Filing Metadata

Form type: 4
Filed: Aug 15, 8:00 PM ET
Accepted: Aug 16, 4:00 PM ET
Size: 4.8 KB

View on SEC.gov